Dual Neutral Sphingomyelinase-2/Acetylcholinesterase Inhibitors for the Treatment of Alzheimer’s Disease
Tina Bilousova(University of California, Los Angeles), Varghese John(University of California, Los Angeles), Bryan J. Simmons(University of California, Los Angeles), Chunni Zhu(University of California, Los Angeles), Jesus Campagna(Foundation for Psychocultural Research), Karen H. Gylys(University of California, Los Angeles), Barbara Jagodzinska(University of California, Los Angeles), Sujyoti Chandra(Stanford University), Rachel R. Knapp(University of California, Los Angeles), Whitaker Cohn(University of California, Los Angeles), Mikhail Melnik(University of California, Los Angeles), Samantha Focht(University of California, Los Angeles), Neil K. Garg(University of California, Los Angeles), Kanagasabai Vadivel(University of California, Los Angeles), Patricia Spilman, Chris Jean Elias(University of California, Los Angeles)
Cited by 33
Related Papers
Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brain
|Journal of Neurochemistry|2001|879
The First Total Synthesis of Dragmacidin D
|Journal of the American Chemical Society|2002|245
Ayurvedic medicinal plants for Alzheimer's disease: a review
|Alzheimer s Research & Therapy|2012|212
Human β-Secretase (BACE) and BACE Inhibitors
|Journal of Medicinal Chemistry|2003|146